Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vitamin D immunomodulatory potential in multiple sclerosis.
Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.
Benefits, safety, and prescription of exercise in persons with multiple sclerosis.
From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
Evidence for a multiple sclerosis epidemic?
A case of acute combined central and peripheral demyelination.
Trial and error in clinical studies: lessons from ATAMS.
Few patients with neurodegenerative disorders require spinal surgery.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions.
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
Evaluation of the effects of reflexology on quality of life and symptomatic relief in multiple sclerosis patients with moderate to severe disability; a pilot study.
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
Does Aquaporin-4-Seronegative Neuromyelitis Optica Exist?
William Austin Sibley, MD (1925-2015).
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.
Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.
Evaluating Neurocognitive Deficits in Patients with Multiple Sclerosis via a Brief Neuropsychological Approach.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »